These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 29091224)

  • 21. New Delhi Metallo-β-lactamase and other mechanisms of carbapenemases among Enterobacteriaceae in rural South India.
    Sekar R; Srivani S; Kalyanaraman N; Thenmozhi P; Amudhan M; Lallitha S; Mythreyee M
    J Glob Antimicrob Resist; 2019 Sep; 18():207-214. PubMed ID: 31181271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of Imipenem-Relebactam and Comparator Agents against Genetically Characterized Isolates of Carbapenem-Resistant Enterobacteriaceae.
    Canver MC; Satlin MJ; Westblade LF; Kreiswirth BN; Chen L; Robertson A; Fauntleroy K; La Spina M; Callan K; Jenkins SG
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of phenotypic methods and polymerase chain reaction for the detection of carbapenemase production in clinical Klebsiella pneumoniae isolates].
    Tekintaş Y; Çilli F; Eraç B; Yaşar M; Aydemir SŞ; Hoşgör Limoncu M
    Mikrobiyol Bul; 2017 Jul; 51(3):269-276. PubMed ID: 28929963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species.
    Haidar G; Alkroud A; Cheng S; Churilla TM; Churilla BM; Shields RK; Doi Y; Clancy CJ; Nguyen MH
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5208-14. PubMed ID: 27297487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo study assessed meropenem and amikacin combination therapy against carbapenem-resistant and carbapenemase-producing Enterobacteriaceae strains.
    Hagihara M; Kato H; Yamashita R; Soda M; Watanabe H; Sakanashi D; Shiota A; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Kitaichi K; Mikamo H
    J Infect Chemother; 2020 Jan; 26(1):1-7. PubMed ID: 31735629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imipenem/relebactam activity compared to other antimicrobials against non-MBL-producing carbapenem-resistant Enterobacteriaceae from an academic medical center.
    Kulengowski B; Burgess DS
    Pathog Dis; 2019 Jun; 77(4):. PubMed ID: 31365075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae.
    Poirel L; Kieffer N; Nordmann P
    J Antimicrob Chemother; 2016 Jan; 71(1):156-61. PubMed ID: 26416781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of specific inhibitors on metallo-β-carbapenemases detected in Escherichia coli and Klebsiella pneumoniae isolates.
    Abbas HA; Kadry AA; Shaker GH; Goda RM
    Microb Pathog; 2019 Jul; 132():266-274. PubMed ID: 31096002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
    Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of in vitro activities of plazomicin and other aminoglycosides against clinical isolates of Klebsiella pneumoniae and Escherichia coli.
    İnce G; Mirza HC; Üsküdar Güçlü A; Gümüş H; Erol Ç; Başustaoğlu A
    J Antimicrob Chemother; 2021 Nov; 76(12):3192-3196. PubMed ID: 34499728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant
    Shortridge D; Kantro V; Castanheira M
    Microbiol Spectr; 2023 Feb; 11(1):e0450722. PubMed ID: 36622238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of ArmA-16S rRNA methyltransferase among aminoglycoside-resistant
    Isler B; Falconer C; Vatansever C; Özer B; Çınar G; Aslan AT; Forde B; Harris P; Şimşek F; Tülek N; Demirkaya H; Menekşe Ş; Akalin H; Balkan İİ; Aydın M; Tigen ET; Demir SK; Kapmaz M; Keske Ş; Doğan Ö; Arabacı Ç; Yağcı S; Hazırolan G; Bakır VO; Gönen M; Saltoğlu N; Azap A; Azap Ö; Akova M; Ergönül Ö; Can F; Paterson DL
    J Med Microbiol; 2022 Dec; 71(12):. PubMed ID: 36748503
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).
    Del Franco M; Paone L; Novati R; Giacomazzi CG; Bagattini M; Galotto C; Montanera PG; Triassi M; Zarrilli R
    BMC Microbiol; 2015 Nov; 15(1):260. PubMed ID: 26552763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC.
    Barnes MD; Taracila MA; Good CE; Bajaksouzian S; Rojas LJ; van Duin D; Kreiswirth BN; Jacobs MR; Haldimann A; Papp-Wallace KM; Bonomo RA
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates.
    Livermore DM; Mushtaq S; Warner M; Zhang JC; Maharjan S; Doumith M; Woodford N
    J Antimicrob Chemother; 2011 Jan; 66(1):48-53. PubMed ID: 21078604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expected plazomicin susceptibility in India based on the prevailing aminoglycoside resistance mechanisms in Gram-negative organisms derived from whole-genome sequencing.
    Pragasam AK; Jennifer SL; Solaimalai D; Muthuirulandi Sethuvel DP; Rachel T; Elangovan D; Vasudevan K; Gunasekaran K; Veeraraghavan B
    Indian J Med Microbiol; 2020; 38(3 & 4):313-318. PubMed ID: 33154241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
    Zhang Y; Wang Q; Yin Y; Chen H; Jin L; Gu B; Xie L; Yang C; Ma X; Li H; Li W; Zhang X; Liao K; Man S; Wang S; Wen H; Li B; Guo Z; Tian J; Pei F; Liu L; Zhang L; Zou C; Hu T; Cai J; Yang H; Huang J; Jia X; Huang W; Cao B; Wang H
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
    Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Fleischmann WA; Greenwood-Quaintance KE; Patel R
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissemination of Carbapenem-resistant Klebsiella pneumoniae clinical isolates with various combinations of Carbapenemases (KPC-2, NDM-1, NDM-4, and OXA-48) and 16S rRNA Methylases (RmtB and RmtC) in Vietnam.
    Tada T; Tsuchiya M; Shimada K; Nga TTT; Thu LTA; Phu TT; Ohmagari N; Kirikae T
    BMC Infect Dis; 2017 Jul; 17(1):467. PubMed ID: 28676118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.